129 related articles for article (PubMed ID: 15764896)
21. 18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
Hugentobler A; Gilbeau L; Talbot JN; Gauthé M
Clin Nucl Med; 2017 Jan; 42(1):e56-e57. PubMed ID: 27775938
[TBL] [Abstract][Full Text] [Related]
22. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
[TBL] [Abstract][Full Text] [Related]
23. Metastatic synovial sarcoma of the scalp: Case report.
Lippert DC; Britt CJ; Pflum ZE; Rush PS; Hartig GK
Head Neck; 2016 Feb; 38(2):E45-8. PubMed ID: 25974105
[TBL] [Abstract][Full Text] [Related]
24. FDG PET/CT differentiating two malignant tumors in the same patient.
Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
[No Abstract] [Full Text] [Related]
25. Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
Charest M; Singnurkar A; Hickeson M; Novales JA; Derbekyan V
Clin Nucl Med; 2008 Jul; 33(7):455-8. PubMed ID: 18580228
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Tian M; Zhang H; Oriuchi N; Higuchi T; Endo K
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1064-72. PubMed ID: 15014903
[TBL] [Abstract][Full Text] [Related]
27. Spindle Cell Sarcoma of the Iliac Vein on 18 F-FDG PET/CT.
Bek CS; Kim HW; Won KS; Song BI
Clin Nucl Med; 2017 Apr; 42(4):293-294. PubMed ID: 28134693
[TBL] [Abstract][Full Text] [Related]
28. Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT.
Jain AS; Simon S; Muthukrishnan I; Gambhir A; Patil S
Clin Nucl Med; 2017 Apr; 42(4):315-318. PubMed ID: 28195904
[TBL] [Abstract][Full Text] [Related]
29. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
30. Solitary pulmonary nodule: pleuropulmonary synovial sarcoma.
Ward RC; Birnbaum AE; Aswad BI; Healey TT
R I Med J (2013); 2014 May; 97(5):40-3. PubMed ID: 24791267
[TBL] [Abstract][Full Text] [Related]
31. Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
Kim JY; Park J; Choi YY; Lee S; Paik SS
Clin Nucl Med; 2015 Feb; 40(2):172-4. PubMed ID: 25140556
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
Vadrucci M; Gilardi L; Crivelli F; Baroli A; Lomuscio G
Clin Nucl Med; 2016 Dec; 41(12):e525-e526. PubMed ID: 27824328
[TBL] [Abstract][Full Text] [Related]
33. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
Eubank WB; Mankoff DA; Takasugi J; Vesselle H; Eary JF; Shanley TJ; Gralow JR; Charlop A; Ellis GK; Lindsley KL; Austin-Seymour MM; Funkhouser CP; Livingston RB
J Clin Oncol; 2001 Aug; 19(15):3516-23. PubMed ID: 11481358
[TBL] [Abstract][Full Text] [Related]
34. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
35. Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Chung A; Schoder H; Sampson M; Morrow M; Port E
Ann Surg Oncol; 2010 Aug; 17(8):2119-25. PubMed ID: 20162459
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
Golan H; Volkov O; Linchinsky O; Melloul M
Nucl Med Rev Cent East Eur; 2005; 8(2):135-6. PubMed ID: 16437401
[TBL] [Abstract][Full Text] [Related]
37. FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging.
Platzek I; Beuthien-Baumann B; Schramm G; Maus J; Laniado M; Kotzerke J; van den Hoff J; Schuler M
Clin Imaging; 2017; 42():126-132. PubMed ID: 27951459
[TBL] [Abstract][Full Text] [Related]
38. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
Vadrucci M; Gilardi L; Grana CM
Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Kubo T; Furuta T; Johan MP; Ochi M
Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
[TBL] [Abstract][Full Text] [Related]
40. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
